Sushree Mohanty, Author at The Motley Fool Australia

Recent Articles

Hand with blue medical gloves holds vials of coronavirus vaccines

International Stock News

Moderna's stock has surged 488% in 2020: Is it a buy for 2021?

December 31, 2020 | Sushree Mohanty

This smaller biotech company attracted a lot of attention in 2020, but is it still worth an investment?

Satisfaction Guaranteed!

The Motley Fool stands behind our products and our membership-fee-back guarantee. If for any reason you are not 100% satisfied with your premium subscription, simply notify us within the first 30 days and you won't pay a cent.

Automatic Renewal

By taking up this offer, you will also be enrolled in our auto-renewal program, which is our way of making your ongoing subscription easier by ensuring uninterrupted service. Don't worry, though – you're not locked in, and can cancel your auto-renewal at any time before each 'anniversary' date without question or penalty.

By Sector

By Topic

Explore More

ASX News

Stock Market Basics

Types of ASX Shares

ASX Market Sectors

Learn How to Invest

What to Invest In

Start Investing in Australia

Investing The Motley Fool Way

Planning for Retirement

Retirement Accounts

Investing for Retirement

For Members

Entry Level Services

Portfolio Services

Bundled Services

Learn More

Our Purpose

Find Us Elsewhere on the Web

Who is The Motley Fool

Sushree Mohanty

Recent Articles

International Stock News

Moderna's stock has surged 488% in 2020: Is it a buy for 2021?

Wondering where you should invest $1,000 right now?